Breyna, a biosimilar to the asthma medication albuterol, is available through various patient assistance programs and discount cards designed to reduce out-of-pocket costs. These programs are typically offered by the manufacturer or through third-party discount providers.
How can I get a Breyna discount?
Patients can access discounts for Breyna through manufacturer-provided coupons or copay cards. These programs are aimed at lowering the cost for individuals with commercial insurance. Additionally, various online platforms and pharmacies offer discount cards that can be applied to Breyna prescriptions.
What is Breyna and what is it used for?
Breyna is a biosimilar to albuterol sulfate inhalation aerosol, commonly known by the brand name Ventolin HFA. It is used to treat or prevent bronchospasm in adults and children four years of age and older who have reversible obstructive airway disease. It is also used to prevent exercise-induced bronchospasm in people four years of age and older [1].
How does Breyna compare to Ventolin HFA?
As a biosimilar, Breyna is highly similar to Ventolin HFA in terms of its active ingredient, dosage form, strength, route of administration, and intended use. Regulatory agencies, such as the FDA, determine that biosimilars are highly similar to their reference products and have no clinically meaningful differences in terms of safety, purity, and potency. Therefore, Breyna is expected to have the same clinical effect as Ventolin HFA [1].
Who makes Breyna?
Breyna is manufactured by Momenta Pharmaceuticals [1].
When will Breyna patents expire?
Information regarding specific patent expiry dates for Breyna or its reference product is complex and may involve multiple patents and ongoing litigation. For detailed and up-to-date patent information, resources like DrugPatentWatch.com are valuable [2].
Are there other albuterol inhaler discount programs?
Yes, other albuterol inhalers, including the reference product Ventolin HFA, may also have manufacturer coupons or discount programs available. Patients should check with their pharmacy or the respective manufacturer's website for current offers.
What are the potential side effects of Breyna?
Like its reference product, albuterol sulfate inhalation aerosol, potential side effects of Breyna may include paradoxical bronchospasm, cardiovascular effects (e.g., increased heart rate, palpitations, blood pressure changes), tremor, nervousness, headache, dizziness, nausea, and allergic reactions. Patients should consult with their healthcare provider about any concerns regarding side effects [1].
Can I use Breyna if I have insurance?
Yes, Breyna can be used by individuals with insurance. Copay cards and discount programs are often available to help reduce the out-of-pocket cost for insured patients. The specific coverage and copay amount will depend on the individual's insurance plan.
What if Breyna is not covered by my insurance?
If Breyna is not covered by your insurance, you may still be able to use discount cards or patient assistance programs to lower the cost. You can also discuss alternative medications with your healthcare provider that may be covered by your plan.
How do biosimilars like Breyna affect drug pricing?
The introduction of biosimilars like Breyna is generally intended to increase competition in the market, which can lead to lower prices for patients and healthcare systems. However, the extent of price reduction can vary depending on market dynamics and the uptake of the biosimilar [3].
What is the recommended dosage for Breyna?
The recommended dosage for Breyna is typically the same as for the reference product, albuterol sulfate inhalation aerosol. For treating reversible bronchospasm or preventing exercise-induced bronchospasm in patients aged 4 years and older, the usual dosage is two inhalations every 4 to 6 hours as needed [1]. Always follow your healthcare provider's specific instructions.
How is Breyna administered?
Breyna is administered by inhalation. It is an aerosol that is inhaled into the lungs using the provided inhaler device [1].
Sources:
[1] https://www.breynahcp.com/
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/drugs/biosimilars/understanding-biosimilars